Skip to main content
. 2020 Jan 31;122(6):766–770. doi: 10.1038/s41416-020-0734-9

Table 2.

Objective responses (n = 71).

N (%) 95% CI
Complete response 9 (12.7) 6.8–22.4
Partial response 50 (70.4) 59.0–79.8
Stable disease 10 (14.1) 7.8–24.0
Progressive disease 0 (0)
Not evaluable 2 (2.8)
Objective response rate 59 (83.1) 72.7–90.1